Immune tolerance induction with mycophenolate‐mofetil in two children with haemophilia B and inhibitor
- 11 December 2007
- journal article
- case report
- Published by Wiley in Haemophilia
- Vol. 14 (1), 44-49
- https://doi.org/10.1111/j.1365-2516.2007.01584.x
Abstract
Immune tolerance induction (ITI) in haemophilia B patients with inhibitor should be carefully considered because of the relatively poor (25%) overall success rate and the high risk of complications. ITI in combination with an immunosuppressive treatment was started in two children with haemophilia B with factor IX (FIX) inhibitor. To avoid anaphylactic reactions and inhibitor boost, the FIX replacement therapy was stopped and patients received a treatment with recombinant activated factor VII (rFVIIa). After disappearance of FIX inhibitor, a combination of mycophenolate-mofetil (MMF), dexamethasone (DEXA) and intravenous immunoglobulin (IVIG) and a high dose FIX replacement therapy was started. Immune tolerance could be induced in patient 2, whereas eradication of FIX inhibitor was incomplete in patient 1. Both patients benefited from the immune suppressive treatment and FIX replacement therapy was tolerated without any allergic complications. Neither development of a nephrotic syndrome nor a severe bleeding episode was observed. Strategies to induce tolerance in haemophilia B patients with inhibitors need to be explored in a systematic way. Given the low frequency of disease and even lower incidence of inhibitors, prospective randomized studies may not be possible. International registry-based retrospective and prospective data collection could play the key role in the study of the outcome variables in ITI for haemophilia B.Keywords
This publication has 20 references indexed in Scilit:
- Achievement of immune tolerance in a patient with haemophilia B and inhibitory antibodies, complicated by an anaphylactoid reactionHaemophilia, 2007
- Current use of by‐passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitorsHaemophilia, 2006
- Cyclosporin A can achieve immune tolerance in a patient with severe haemophilia B and refractory inhibitorsHaemophilia, 2006
- Value of therapeutic drug monitoring of MMF therapy in pediatric transplantationPediatric Transplantation, 2006
- Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitorsHaemophilia, 2006
- The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors OrganisationBritish Journal of Haematology, 2006
- Rituximab for adolescents with haemophilia and high titre inhibitorsHaemophilia, 2006
- New Approaches in the Management of Inhibitor PatientsActa Haematologica, 2006
- Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophiliaBritish Journal of Haematology, 2004
- Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitorsHaemophilia, 2002